Lantheus Holdings, Inc.

LNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $1.54B $1.53B $1.30B $935.1M $425.2M $339.4M $347.3M $343.4M
Cost of Revenue $599.7M $545.6M $586.9M $353.4M $237.5M $200.6M $172.5M $168.5M
Gross Profit $942.0M $988.3M $709.5M $581.7M $187.7M $138.8M $174.8M $174.9M
Gross Margin 61.1% 64.4% 54.7% 62.2% 44.1% 40.9% 50.3% 50.9%
Operating Expenses
Research & Development $177.3M $168.1M $77.7M $311.7M $45.0M $32.8M $20.0M $17.1M
SG&A Expense $275.1M $193.7M $125.5M $133.6M $150.4M $69.3M $61.2M $50.2M
Operating Income $310.8M $457.0M $364.6M $36.2M $-60.8M $-4.2M $51.7M $64.5M
Operating Margin 20.2% 29.8% 28.1% 3.9% -14.3% -1.2% 14.9% 18.8%
Interest Expense $20.0M $7.2M $7.8M $9.5M $13.6M $17.4M
Pretax Income $313.8M $431.0M $410.9M $26.7M $-75.0M $-11.5M $28.6M $49.5M
Income Tax Expense $80.2M $118.5M $84.3M $-1.3M $-3.8M $2.0M $-3.0M $9.0M
Net Income $233.6M $312.4M $326.7M $28.1M $-71.3M $-13.5M $31.7M $40.5M
Net Margin 15.2% 20.4% 25.2% 3.0% -16.8% -4.0% 9.1% 11.8%
EPS (Basic) $3.46 $4.52 $4.79 $0.41 $-1.06 $-0.25 $0.81 $1.06
EPS (Diluted) $3.41 $4.36 $4.65 $0.40 $-1.06 $-0.25 $0.79 $1.03
Shares Outstanding (Basic) 67.5M 69.2M 68.3M 68.5M 67.5M 54.1M 39.0M 38.2M
Shares Outstanding (Diluted) 68.4M 71.7M 70.2M 70.7M 67.5M 54.1M 40.1M 39.5M
Dividends Per Share
← Newer Page 1 of 2 Older →